PAROS: LaPAroscopic Low pRessure cOlorectal Surgery

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Completed
CT.gov ID
NCT03813797
Collaborator
(none)
138
1
2
17.6
7.8

Study Details

Study Description

Brief Summary

Laparoscopy by its mini-invasive character has revolutionized abdominal and colorectal surgery but certain limitations remains (post-operative pain due to pneumoperitoneum, pneumoperitoneum stability, visibility during bleeding, smoke evacuation). The medical device for continuous pressure insufflation during laparoscopic procedures Airseal® would allow the maintenance of pneumoperitoneum at a lower pressure. The stable low pressure (7mmHg) is described in the literature for 15 years as the best way to reduce scapular pain, but until the marketing of Airseal, working at 7mmHg was not possible because the space of work was not stable. Moreover, this device makes it possible to obtain a better vision because of the evacuation of the fumes potentially leading to a reduction in the operating time.

Condition or Disease Intervention/Treatment Phase
  • Device: Airseal®
  • Device: Standard Insufflation
N/A

Detailed Description

This research focuses on a medical device that allows the surgeon to perform the surgical procedure at a lower pressure than usual.

The main objective of this study is to compare the duration of hospitalization of patients with laparoscopic colectomy at low pressure (5-7 mmHg) versus standard pressure (12-15 mmHg) It is a prospective randomized monocentric double blind study

Study Design

Study Type:
Interventional
Actual Enrollment :
138 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
The study will be carried out: Blind patient: The patient will not know the group he belongs to, in order to minimize the bias related to the self-evaluation of postoperative pain Blind for the outpatient evaluator: the surgeon will blindly evaluate the primary endpoint: patient's discharge criteria. This "evaluator" surgeon will be different from the "operator" surgeon The blind will minimize the measurement bias.
Primary Purpose:
Treatment
Official Title:
LaPAroscopic Low pRessure cOlorectal Surgery
Actual Study Start Date :
Jan 7, 2019
Actual Primary Completion Date :
May 25, 2020
Actual Study Completion Date :
Jun 26, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm A: Low Pressure (5-7 mmHg)

Laparoscopic colectomy surgery with low pressure (5-7mmHg)

Device: Airseal®
Medical device set to the mode Airseal®, pressure adjustment between 5 and 7 mmHg

Active Comparator: Arm B: Standard pressure (12-15 mmHg)

Laparoscopic colectomy surgery with standard pressure (12-15mmHg)

Device: Standard Insufflation
Medical device set to the mode "Standard Insufflation", pressure adjustment between 12 and 15 mmHg

Outcome Measures

Primary Outcome Measures

  1. Length of postoperative hospital stay [From surgery to the end of the hospitalization (max 30 days)]

    To determine the length of hospitalization

Secondary Outcome Measures

  1. Surgery time [During surgery]

    To determine the surgery time

  2. Appreciation of visual quality by surgeon [During surgery]

    To determine the rate of visual quality during surgery: poor, medium or good quality

  3. Impact of the use of microlaparoscopic instruments [During surgery]

    To determine the rate of use of the microsurgery microlaparoscopic instruments (3mm)

  4. Rates of conversion [During surgery]

    Conversion to laparoscopy with standard pressure or conversion to laparotomy

  5. Blood pressure (mmHg) [During surgery]

    To examine the variation of blood pressure during surgery (at the beginning, middle and at the end)

  6. Cardiac frequency (/ min) [During surgery]

    To examine the variation of cardiac frequency during surgery (at the beginning, middle and at the end)

  7. Volume replacement (mL) [During surgery]

    To examine the volume replacement during surgery (at the beginning, middle and at the end)

  8. Driving pressure (mmHg) [During surgery]

    To examine the variation of drinving pressure during surgery (at the beginning, middle and at the end)

  9. Oxygen saturation (%) [During surgery]

    To examine the variation of SA02 (%) during surgery (at the beginning, middle and at the end)

  10. Partial pressure of mean expired of carbon dioxide (mmHg) [During surgery]

    To examine the variation PECO2 (mmHg) during surgery (at the beginning, middle and at the end)

  11. Surgical and medical morbidity [From surgery until 30 days (max 45 days)]

    To analyse the cumulative Clavien-Dindo at 30 days

  12. Postoperative pain [2 hours, 4 hours, 8 hours and 24 hours after the surgery]

    Pain was evaluated with the Numeric Rating Scale (NRS, from 0 (no pain) to 10 (hurts worst)

  13. Use of analgesics [An average of 5 days after the surgery]

    To evaluate the rate of analgesics administrated (from step1 to step3)

  14. Time before the passage of first stool (days) [An average of 5 days after the surgery]

    To determine the delay of the laxation and gas response

  15. Time before the passage of first gas (days) [An average of 5 days after the surgery]

    To determine the delay of the gas response

  16. Time before mobilization (Days before 1st time sitting and standing) [An average of 5 days after the surgery]

    To determine the delay before mobilization

  17. Quality of cancer surgery [During surgery]

    Rate of curative surgery (R0)

  18. Number of lymph nodes examed [During surgery]

    Number of lymph nodes examed during a cancer surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18

  • Colonic resection (right or left) performed for benign or malignant pathology

  • Laparoscopic procedure

  • Informed consent signed

  • Social Insurance

Exclusion Criteria:
  • Laparotomy procedure

  • Associated resection (except appendectomy or liver biopsy

  • Emergency procedure

  • Pelvic sepsis

  • Pregnant or breast-feeding woman.

  • Persons deprived of liberty or under guardianship

  • Impossibility for compliance to follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu de Bordeaux Bordeaux France

Sponsors and Collaborators

  • University Hospital, Bordeaux

Investigators

  • Principal Investigator: Quentin DENOST, University Hospital, Bordeaux

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT03813797
Other Study ID Numbers:
  • CHUBX 2018/42
First Posted:
Jan 23, 2019
Last Update Posted:
Oct 8, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Bordeaux

Study Results

No Results Posted as of Oct 8, 2020